EcoDrugPlus

Janus Kinase 1

Ensembl ID : ENSCHAG00000003626
Gene Symbol: JAK1
3 Cross references
167 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSCHAG00000008676
Gene Symbol: JAK2A
1 Cross references
198 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSCHAG00000021388
Gene Symbol: MAPKAPK2
1 Cross references
132 Possible Orthologues:

Mapk Activated Protein Kinase 2b

Ensembl ID : ENSCHAG00000023946
Gene Symbol: MAPKAPK2B
1 Cross references
171 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSCHAG00000008918
Gene Symbol: MAPKAPK5
1 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSCHAG00000016071
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSCHAG00000006190
Gene Symbol: MDM2
1 Cross references
285 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCHAG00000024193
Gene Symbol: MET
1 Cross references
205 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSCHAG00000023370
Gene Symbol: MLST8
3 Cross references
195 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSCHAG00000012912
Gene Symbol: NPC1L1
1 Cross references
190 Possible Orthologues:

Nt-3 Growth Factor Receptor-Like

Ensembl ID : ENSCHAG00000016223
Gene Symbol: LOC105892129
3 Cross references
157 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSCHAG00000020730
Gene Symbol: PTK6B
1 Cross references
160 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).